Zobrazeno 1 - 10
of 1 167
pro vyhledávání: '"E. Piccioni"'
Publikováno v:
Il Foro Italiano, 1918 Jan 01. 43, 937/938-945/946.
Externí odkaz:
https://www.jstor.org/stable/23118988
Autor:
Paul Manning, Shanmukha Srinivas, Divya S. Bolar, Matthew K. Rajaratnam, David E. Piccioni, Carrie R. McDonald, Jona A. Hattangadi-Gluth, Nikdokht Farid
Publikováno v:
Frontiers in Radiology, Vol 4 (2024)
PurposeConventional contrast-enhanced MRI is currently the primary imaging technique used to evaluate radiation treatment response in meningiomas. However, newer perfusion-weighted MRI techniques, such as 3D pseudocontinuous arterial spin labeling (3
Externí odkaz:
https://doaj.org/article/ec81c74f845f477685e71f7848c5c912
Autor:
Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-9 (2022)
Abstract Background Vaccine immunotherapy may improve survival in Glioblastoma (GBM). A multicenter phase II trial was designed to determine: (1) the success rate of manufacturing the Aivita GBM vaccine (AV-GBM-1), (2) Adverse Events (AE) associated
Externí odkaz:
https://doaj.org/article/5a31d54aac0647619b0bae78c1eddb03
Autor:
Siqing Fu, David E. Piccioni, Hongtao Liu, Rimas V. Lukas, Santosh Kesari, Dawit Aregawi, David S. Hong, Kenichiro Yamaguchi, Kate Whicher, Yi Zhang, Yu-Luan Chen, Nagaraju Poola, John Eddy, David Blum
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract WT2725 is a Wilms’ tumor gene 1 (WT1)-derived-oligopeptide vaccine designed to induce WT1-specific cytotoxic T-lymphocytes against WT1+ tumors in human leukocyte antigen (HLA)-A*0201+ and/or HLA-A*0206+ patients. Here, we report the result
Externí odkaz:
https://doaj.org/article/60746137df784b578782dc3342f39baf
Publikováno v:
Interdisciplinary Neurosurgery, Vol 28, Iss , Pp 101526- (2022)
Background and Importance:: Staged surgery has been used to treat large skull base tumors but is rarely used for intrinsic brain tumors, despite the fact that extent of resection (EOR) is associated with improved survival. A number of questions remai
Externí odkaz:
https://doaj.org/article/07bdb83d9c734e72a6555f60fde5d192
Autor:
Lindsey M. Charo, Ramez N. Eskander, Ryosuke Okamura, Sandip P. Patel, Mina Nikanjam, Richard B. Lanman, David E. Piccioni, Shumei Kato, Michael T. McHale, Razelle Kurzrock
Publikováno v:
Molecular Oncology, Vol 15, Iss 1, Pp 67-79 (2021)
Molecular characterization of cancers is important in dictating prognostic factors and directing therapy. Next‐generation sequencing of plasma circulating tumor DNA (ctDNA) offers less invasive, more convenient collection, and a more real‐time re
Externí odkaz:
https://doaj.org/article/7a9c92dc08dc477d922323db2172ffe6
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-5 (2018)
Abstract Background Neurologic toxicities with immune therapy are rare, but can cause devastating and often permanent injury when they occur. Although there is increasing interest in the potential synergism between immune therapy and radiation, it is
Externí odkaz:
https://doaj.org/article/96391bc275fa40fca82d3b58c60e9ecd
Autor:
Priscilla K. Brastianos, Erin L. Twohy, Elizabeth R. Gerstner, Timothy J. Kaufmann, A. John Iafrate, Jochen Lennerz, Suriya Jeyapalan, David E. Piccioni, Varun Monga, Camilo E. Fadul, David Schiff, Jennie W. Taylor, Sajeel A. Chowdhary, Chetan Bettegowda, George Ansstas, Macarena De La Fuente, Mark D. Anderson, Nicole Shonka, Denise Damek, Jose Carrillo, Lara J. Kunschner-Ronan, Rekha Chaudhary, Kurt A. Jaeckle, Francis M. Senecal, Thomas Kaley, Tara Morrison, Alissa A. Thomas, Mary R. Welch, Fabio Iwamoto, David Cachia, Adam L. Cohen, Shivangi Vora, Michael Knopp, Ian F. Dunn, Priya Kumthekar, Jann Sarkaria, Susan Geyer, Xiomara W. Carrero, Maria Martinez-Lage, Daniel P. Cahill, Paul D. Brown, Caterina Giannini, Sandro Santagata, Frederick G. Barker, Evanthia Galanis
Publikováno v:
Journal of Clinical Oncology. 41:618-628
PURPOSE Patients with progressive or recurrent meningiomas have limited systemic therapy options. Focal adhesion kinase (FAK) inhibition has a synthetic lethal relationship with NF2 loss. Given the predominance of NF2 mutations in meningiomas, we eva
Autor:
Shadi Daghighi, Naeim Bahrami, William J. Tom, Nicholas Coley, Tyler M. Seibert, Jona A. Hattangadi-Gluth, David E. Piccioni, Anders M. Dale, Nikdokht Farid, Carrie R. McDonald
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Immunotherapy is increasingly used in the treatment of glioblastoma (GBM), with immune checkpoint therapy gaining in popularity given favorable outcomes achieved for other tumors. However, immune-mediated (IM)-pseudoprogression is common, remains poo
Externí odkaz:
https://doaj.org/article/5b70c6de3df044e0ac2a8c1e182577de